SUFU 2021: Distinguishing Features of the Urinary Bacterial Microbiome in Patients With Neurogenic Bladder

(UroToday.com) This was a prospective cross-sectional study of individuals with neurogenic bladder who performed intermittent catheterization (CIC, n=51) or utilized an indwelling catheter (n=16) that aimed to characterize the microbiota and to evaluate differences based on the type of bladder management or frequency of symptomatic urinary tract infections (UTI).

SUFU 2021: Disparity in Female Pelvic Examination in the Evaluation of Lower Urinary Tract Symptoms

(UroToday.com) The primary objective of this study was to investigate the disparity of pelvic and genitourinary (GU) exams between male and female patients who present with lower urinary tract symptoms (LUTS), urinary tract infection (UTI), and other urological conditions as well as, assess for predictors of undergoing pelvic examination. This was a retrospective chart review performed […]

Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries.

Background: Renal cell carcinoma (RCC) is divided into three major histopathologic groups-clear cell (ccRCC), papillary (pRCC) and chromophobe RCC (chRCC). We performed a comprehensive re-analysis of publicly available RCC datasets from the TCGA (The Cancer Genome Atlas) database, thereby combining samples from all three subgroups, for an exploratory transcriptome profiling of RCC subgroups.

Assessing Response to [177Lu]PSMA Radioligand Therapy using modified PSMA PET Progression Criteria.

Introduction: Positron emission tomography/computer tomography (PET/CT) targeting the prostate specific membrane antigen (PSMA) plays a key role in staging of patients with prostate cancer (PCa). Moreover, it is not only used for the assessment of adequate PSMA expression of PCa cells before PSMA-targeting radioligand therapy (PSMA RLT) but also for re-staging during the course of […]

X